Applying a matrix approach for potency assay development for in vivo and ex vivo gene therapies
Broadcast dateMon, Mar 14, 2022
- Dominic Hildebrand - BayerShihua Lin - AstraZeneca
The webinar aims to bring an awareness of the challenges associated with developing potency assays that adequately reflect the mechanism of action (MoA) of gene therapies (GTs).
Head of Laboratory, Analytical Development and Quality Control